Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05457725 · ClinicalTrials.gov registry record · NA

Modulating Neurocognitive Processes of Learning to Trust and Distrust in Aging

A NA study of Aging and Cognitive Change, sponsored by University of Florida.

Recruiting
Registry status
NA
Development phase
68
Enrollment target
1
Study location

NCT05457725: Recruiting NA study of Aging and Cognitive Change, sponsored by University of Florida.

NCT05457725 is a NA study of Aging and Cognitive Change that is actively recruiting participants, run by University of Florida. The registered enrollment target is 68 participants, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05457725, a NA study of Aging and Cognitive Change, is actively recruiting participants, sponsored by University of Florida.

RECRUITING
Registry status
NA
Development phase
68 participants
Enrollment target
1
Study location

Study Summary

Much of human interaction is based on trust. Aging has been associated with deficits in trust-related decision making, likely further exacerbated in age-associated neurodegenerative disease (Alzheimer's disease/AD), possibly underlying the dramatically growing public health problem of elder fraud. Optimal trust-related decision making and avoiding exploitation require the ability to learn about the trustworthiness of social partners across multiple interactions, but the role that learning plays in determining age deficits in trust decisions is currently unknown. Aim: Probe the malleability of the underlying neurocircuitry of trust-learning deficits in aging. This study will utilize real-time fMRI neurofeedback to train older adults in brain activity up-regulation toward enhanced trust-related learning in aging and confirm critical mechanisms of experience-dependent social decisions in aging. Grant R01AG072658 Aim 3: Test the malleability of trust-learning neurocircuitry toward optimized trust-related decision making in aging.

Primary Outcome

Increase in BOLD signal in ROI during up-regulation trials administration of computerized learning tasks, with contrasting groups and conditions

Interventions

  • BEHAVIORAL Contingent rtfMRI neurofeedback training
  • BEHAVIORAL Non-contingent/sham rtfMRI neurofeedback training

Study Locations (1)

Florida

  • University of Florida - Gainesville

Trial Details

FieldValue
Enrollment Target 68 participants
Start Date 2024-10-08
Est. Completion 2027-04-30
Phase NA
University of Florida

1,106 total trials

What NCT05457725 shows while recruiting

NCT05457725 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 68 participants, a relatively small participant target, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (97% lower).

The record links to 3 conditions, with Aging appearing as the primary indexed condition, and to 2 interventions - of which Contingent rtfMRI neurofeedback training is the first listed.

NCT05457725 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT05457725 about?

NCT05457725 is a clinical study titled "Modulating Neurocognitive Processes of Learning to Trust and Distrust in Aging". Much of human interaction is based on trust. Aging has been associated with deficits in trust-related decision making, likely further exacerbated in age-associated neurodegenerative disease (Alzheimer's disease/AD), possibly underlying the dramatically growing public health problem of elder fraud. O...

What is the current status of trial NCT05457725?

This trial is currently recruiting. It is a NA study. The enrollment target is 68 participants. The study started on 2024-10-08. Estimated completion is 2027-04-30.

What conditions does trial NCT05457725 study?

This clinical trial studies the following conditions: Aging, Cognitive Change, Neurocognitive Disorders, Mild.

What interventions are being tested in trial NCT05457725?

The interventions under investigation include: Contingent rtfMRI neurofeedback training (BEHAVIORAL), Non-contingent/sham rtfMRI neurofeedback training (BEHAVIORAL).

Who is sponsoring clinical trial NCT05457725?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05457725 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05457725's enrollment target sits among peer trials

68 128th of 262 higher than 134 of 262 other Aging trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02044497 · 68 participants · Phase 4

    Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients

  • NCT03779854 · 68 participants · Phase 2

    Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

  • NCT03821246 · 68 participants · Phase 2

    Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy

  • NCT04115514 · 68 participants · Phase 2

    Treatment of ARDS With Instilled T3

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05457725, the US trial registry maintained by the National Library of Medicine. NCT05457725 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.